New therapy aims to ease emotional burden for cancer caregivers
NCT ID NCT06630351
First seen Jun 27, 2026 · Last updated Aug 07, 2026 · Updated 1 time
Summary
This study tests whether a virtual group therapy program can help caregivers of people with advanced cancer or serious life-limiting illness feel less hopeless and more connected to meaning and purpose. About 80 caregivers will participate in the program, which focuses on reducing emotional burden and improving well-being. The goal is to see if this approach is practical and helpful for caregivers.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 80 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Sep 2024
- Expected to finish
-
Dec 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age \>= 18 years * English fluency * No diagnosed severe cognitive impairment * Caregiver of a patient with a diagnosis of advanced, solid tumor cancer (stage III/stage IV), caregivers supporting a patient with a serious life-limiting illness * Provide written (paper or electronic) informed consent * Ability to complete questionnaire(s) by themselves or with assistance * Patient baseline distress score \>= 4/10 * Have ability to utilize the technology to participate in virtual groups Exclusion Criteria: * As determined through self-report, those diagnosed with a history of a psychotic episode will be excluded * Other psychological co-morbidities such as untreated schizophrenia, bipolar disease * Cognitive impairment likely to interfere with participation
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Advanced malignant solid neoplasm are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
2 sites. The list below names each one and where it is.
-
The official record
The full official record for this study. This one lists no contact details, but it is the first place any would appear.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Mayo Clinic in Florida
Jacksonville, Florida, 32224-9980, United States
-
Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a protein calm the immune System's overreaction to cancer treatment?
- New drug combo aims to shrink Hard-to-Treat pancreatic and ovarian tumors
- Engineered immune cells take aim at Hard-to-Treat cancers
- Vaccine trains immune system to hunt down cancer cells
- Wheat germ supplement studied for immune boost in advanced cancer
- New drug targets hard-to-treat cancers in early trial